Acquired FGFR and FGF alterations confer resistance to Estrogen Receptor (ER) targeted therapy in ERþ metastatic breast cancer

Pingping Mao, Ofir Cohen, Kailey J. Kowalski, Justin G. Kusiel, Jorge E. Buendia-Buendia, Michael S. Cuoco, Pedro Exman, Seth A. Wander, Adrienne G. Waks, Utthara Nayar, Jon Chung, Samuel Freeman, Orit Rozenblatt-Rosen, Vincent A. Miller, Federica Piccioni, David E. Root, Aviv Regev, Eric P. Winer, Nancy U. Lin, Nikhil Wagle

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Acquired FGFR and FGF alterations confer resistance to Estrogen Receptor (ER) targeted therapy in ER<sup>þ</sup> metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences